Update on Pharmaceutical and Minimally Invasive Management Strategies for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a debilitating pulmonary disorder with systemic effects, and it is the fourth leading cause of death in the United States. COPD patients not only develop respiratory limitations, but can also demonstrate systemic wasting, features of depression, and ca...
Main Authors: | Rokhsara Rafii, Timothy E. Albertson, Samuel Louie, Andrew L. Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/257496 |
Similar Items
-
Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
by: Soma Jyothula, et al.
Published: (2009-09-01) -
Why understanding the asthma chronic obstructive pulmonary disease overlap syndrome (ACOS) is important to the clinician
by: T E Albertson
Published: (2016-01-01) -
Gender differences and chronic obstructive pulmonary disease: an update on the literature
by: Elena Barbagelata, et al.
Published: (2018-09-01) -
The Ventilatory Strategy to Minimize Expiratory Flow Rate in Ventilated Patients with Chronic Obstructive Pulmonary Disease
by: Tsuboi N, et al.
Published: (2021-02-01) -
Invasive Aspergillosis in Patients with Chronic Obstructive Pulmonary Diseases
by: Aziz Muquim, et al.
Published: (2005-01-01)